Related Experiment Videos
New tests for bacterial sexually transmitted diseases.
1Division of AIDS, STDs and Tuberculosis Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. sam1@cdc.gov
Current Opinion in Infectious Diseases
|April 30, 2002
Summary
New diagnostic tools enhance syphilis testing sensitivity and stability. Advanced nucleic acid tests offer user-friendly, high-throughput detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
Area of Science:
- Clinical diagnostics
- Microbiology
- Infectious diseases
Background:
- Syphilis, Chlamydia trachomatis, and Neisseria gonorrhoeae are significant public health concerns.
- Accurate and efficient diagnostic methods are crucial for controlling sexually transmitted disease (STD) outbreaks.
Purpose of the Study:
- To introduce novel advancements in STD diagnostic testing.
- To improve the performance of syphilis serologic tests.
- To develop a more accessible and efficient test for common bacterial STDs.
Main Methods:
- Development of a synthetic Venereal Disease Research Laboratory (VDRL) reagent for syphilis testing.
- Creation of a second-generation nucleic acid amplification test (NAAT) for Chlamydia trachomatis and Neisseria gonorrhoeae.
Main Results:
- The synthetic VDRL reagent demonstrates improved sensitivity and stability in nontreponemal serologic tests for syphilis.
- The new NAAT is user-friendly and capable of high-throughput screening for Chlamydia trachomatis and Neisseria gonorrhoeae.
Conclusions:
- These advancements offer improved diagnostic capabilities for syphilis.
- The developed NAAT provides a more efficient and accessible method for diagnosing Chlamydia and gonorrhea infections.